OraSure Technologies Gross Profit 2010-2025 | OSUR

OraSure Technologies gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
OraSure Technologies Annual Gross Profit
(Millions of US $)
2024 $79
2023 $172
2022 $148
2021 $118
2020 $102
2019 $95
2018 $114
2017 $99
2016 $88
2015 $80
2014 $67
2013 $59
2012 $56
2011 $52
2010 $47
2009 $47
OraSure Technologies Quarterly Gross Profit
(Millions of US $)
2025-03-31 $12
2024-12-31 $14
2024-09-30 $17
2024-06-30 $25
2024-03-31 $24
2023-12-31 $35
2023-09-30 $44
2023-06-30 $26
2023-03-31 $66
2022-12-31 $50
2022-09-30 $47
2022-06-30 $28
2022-03-31 $24
2021-12-31 $27
2021-09-30 $21
2021-06-30 $31
2021-03-31 $38
2020-12-31 $38
2020-09-30 $30
2020-06-30 $17
2020-03-31 $16
2019-12-31 $30
2019-09-30 $22
2019-06-30 $25
2019-03-31 $18
2018-12-31 $35
2018-09-30 $29
2018-06-30 $26
2018-03-31 $24
2017-12-31 $29
2017-09-30 $25
2017-06-30 $25
2017-03-31 $20
2016-12-31 $24
2016-09-30 $23
2016-06-30 $21
2016-03-31 $20
2015-12-31 $22
2015-09-30 $21
2015-06-30 $21
2015-03-31 $17
2014-12-31 $18
2014-09-30 $19
2014-06-30 $16
2014-03-31 $14
2013-12-31 $17
2013-09-30 $15
2013-06-30 $14
2013-03-31 $12
2012-12-31 $13
2012-09-30 $14
2012-06-30 $15
2012-03-31 $14
2011-12-31 $15
2011-09-30 $14
2011-06-30 $12
2011-03-31 $11
2010-12-31 $12
2010-09-30 $12
2010-06-30 $12
2010-03-31 $11
2009-12-31 $12
2009-09-30 $14
2009-06-30 $10
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.239B $0.186B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $223.656B 26.24
Boston Scientific (BSX) United States $157.946B 37.72
Stryker (SYK) United States $152.832B 31.96
EssilorLuxottica (ESLOY) France $137.378B 0.00
Medtronic (MDT) Ireland $117.532B 16.66
Lonza Group Ag (LZAGY) Switzerland $49.462B 0.00
Haleon (HLN) United Kingdom $43.306B 24.72
ResMed (RMD) United States $40.680B 30.56
Agilent Technologies (A) United States $33.534B 21.86
GE HealthCare Technologies (GEHC) United States $32.803B 15.37
Koninklijke Philips (PHG) Netherlands $25.816B 17.08
Terumo (TRUMY) Japan $25.125B 32.63
Insulet (PODD) United States $20.991B 82.39
Zimmer Biomet Holdings (ZBH) United States $18.463B 11.86
Baxter (BAX) United States $14.395B 10.75
Smith & Nephew SNATS (SNN) United Kingdom $13.547B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.805B 23.68
Lantheus Holdings (LNTH) United States $4.970B 12.54
Perrigo (PRGO) Ireland $3.781B 9.58
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.644B 16.60
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.383B 28.11
ICU Medical (ICUI) United States $3.088B 22.77
LeMaitre Vascular (LMAT) United States $1.852B 41.40
AtriCure (ATRC) United States $1.739B 0.00
QuidelOrtho (QDEL) United States $1.643B 11.30
Acuren (TIC) United States $1.391B 0.00
Green Thumb Industries (GTBIF) United States $1.271B 28.60
AdaptHealth (AHCO) United States $1.232B 12.51
Phibro Animal Health (PAHC) United States $1.132B 14.47
BioLife Solutions (BLFS) United States $1.044B 0.00
Neogen (NEOG) United States $1.019B 16.19
Curaleaf Holdings (CURLF) Canada $0.939B 0.00
InMode (INMD) Israel $0.879B 8.13
Kestra Medical Technologies (KMTS) United States $0.856B 0.00
Valneva SE (VALN) France $0.651B 0.00
Tilray Brands (TLRY) Canada $0.616B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.614B 0.00
Evolus (EOLS) United States $0.578B 0.00
Owens & Minor (OMI) United States $0.549B 4.56
CeriBell (CBLL) United States $0.539B 0.00
Surmodics (SRDX) United States $0.535B 0.00
ZimVie (ZIMV) United States $0.526B 20.52
SNDL (SNDL) Canada $0.378B 0.00
Capricor Therapeutics (CAPR) United States $0.374B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.342B 0.00
Cresco Labs (CRLBF) United States $0.315B 0.00
Sanuwave Health (SNWV) United States $0.308B 0.00
VAREX IMAGING (VREX) United States $0.307B 11.29
Quanterix (QTRX) United States $0.304B 0.00
Aurora Cannabis (ACB) Canada $0.254B 75.33
Cerus (CERS) United States $0.250B 0.00
Viemed Healthcare (VMD) United States $0.244B 20.60
Omeros (OMER) United States $0.238B 0.00
Biote (BTMD) United States $0.237B 6.68
Sanara MedTech (SMTI) United States $0.223B 0.00
Brainsway (BWAY) Israel $0.222B 58.75
Canopy Growth (CGC) Canada $0.215B 0.00
Verano Holdings (VRNOF) United States $0.215B 0.00
Exagen (XGN) United States $0.190B 0.00
Organigram Global (OGI) Canada $0.184B 0.00
Utah Medical Products (UTMD) United States $0.183B 15.07
Vireo Growth (VREOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.172B 0.00
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
TerrAscend (TSNDF) Canada $0.131B 0.00
FitLife Brands (FTLF) United States $0.117B 14.37
Jushi Holdings (JUSHF) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.62
MacroGenics (MGNX) United States $0.097B 0.00
Quipt Home Medical (QIPT) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Veru (VERU) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.072B 0.00
InterCure (INCR) Israel $0.067B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
United-Guardian (UG) United States $0.036B 12.51
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00